yohimbine has been researched along with Chemical Dependence in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 5 (55.56) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, C; Anderson, D; Harre, N; Wade, N | 1 |
Bossert, JM; Liu, SY; Shaham, Y; Shepard, JD | 1 |
Collier, HO; Tucker, JF | 1 |
Henningfield, JE; Jaffe, JH; Klein, S; Meisch, RA; Roache, JD; Sampson, A | 1 |
Charney, DS; Cooney, N; Kranzler, HR; Krystal, JH; Webb, E | 1 |
Black, JE; Heninger, GR; Kosten, TR; Malison, RT; McDougle, CJ; Price, LH; Zimmermann, RC | 1 |
Aley, KO; Levine, JD | 1 |
Hameedi, FA; Kosten, TR; Pearsall, HR; Rosen, MI; Woods, SW | 1 |
Azizi, MR; Dehpour, AR; Farahani, M; Javidan, AN; Namiranian, K; Sadr, SS | 1 |
1 review(s) available for yohimbine and Chemical Dependence
Article | Year |
---|---|
Sites and mechanisms of dependence in the myenteric plexus of guinea pig ileum.
Topics: Acetylcholine; Adenosine; Animals; Clonidine; Cyclic AMP; Guinea Pigs; Humans; Ileum; In Vitro Techniques; Morphine; Morphine Dependence; Morphine Derivatives; Muscle Contraction; Muscle, Smooth; Myenteric Plexus; Naloxone; Pertussis Vaccine; Scopolamine; Substance P; Substance Withdrawal Syndrome; Substance-Related Disorders; Theophylline; Yohimbine | 1984 |
4 trial(s) available for yohimbine and Chemical Dependence
Article | Year |
---|---|
Reinforcing effects of triazolam in sedative abusers: correlation of drug liking and self-administration measures.
Topics: Adult; Anxiety; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Hypnotics and Sedatives; Male; Reinforcement Schedule; Reinforcement, Psychology; Self Administration; Substance-Related Disorders; Triazolam; Yohimbine | 1995 |
Specificity of ethanollike effects elicited by serotonergic and noradrenergic mechanisms.
Topics: Adult; Affect; Alcohol Drinking; Alcoholism; Anxiety; Blood Pressure; Cocaine; Ethanol; Hospitalization; Humans; Hydrocortisone; Male; Marijuana Abuse; Middle Aged; Piperazines; Placebos; Prolactin; Receptors, Adrenergic; Receptors, Serotonin; Substance-Related Disorders; Yohimbine | 1994 |
Noradrenergic dysregulation during discontinuation of cocaine use in addicts.
Topics: Administration, Intranasal; Adult; Cocaine; Double-Blind Method; Female; Hospitalization; Humans; Hydrocortisone; Infusions, Intravenous; Insufflation; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Panic Disorder; Prospective Studies; Single-Blind Method; Substance Withdrawal Syndrome; Substance-Related Disorders; Yohimbine | 1994 |
Dose dependent effects of yohimbine on methadone maintained patients.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; In Vitro Techniques; Male; Methadone; Middle Aged; Naloxone; Narcotic Antagonists; Narcotics; Substance Withdrawal Syndrome; Substance-Related Disorders; Yohimbine | 1997 |
4 other study(ies) available for yohimbine and Chemical Dependence
Article | Year |
---|---|
Case study: two fatal case reports of acute yohimbine intoxication.
Topics: Adult; Enzyme-Linked Immunosorbent Assay; Fatal Outcome; Gas Chromatography-Mass Spectrometry; Humans; Illicit Drugs; Male; Substance Abuse Detection; Substance-Related Disorders; Yohimbine; Young Adult | 2013 |
The anxiogenic drug yohimbine reinstates methamphetamine seeking in a rat model of drug relapse.
Topics: Adrenergic alpha-Antagonists; Animals; Behavior, Addictive; Behavior, Animal; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Electroshock; Extinction, Psychological; Male; Methamphetamine; Models, Animal; Rats; Rats, Long-Evans; Self Administration; Substance-Related Disorders; Time Factors; Yohimbine | 2004 |
Multiple receptors involved in peripheral alpha 2, mu, and A1 antinociception, tolerance, and withdrawal.
Topics: Adenosine; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Analgesics; Analgesics, Opioid; Animals; Clonidine; Dinoprostone; Drug Interactions; Drug Tolerance; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Hyperalgesia; Male; Models, Biological; Naloxone; Narcotic Antagonists; Oligonucleotides, Antisense; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Opioid, mu; Receptors, Purinergic P1; Second Messenger Systems; Substance Withdrawal Syndrome; Substance-Related Disorders; Xanthines; Yohimbine | 1997 |
Lithium inhibits the development of physical dependence to clonidine in mice.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Animals; Clonidine; Injections, Intraperitoneal; Lithium; Male; Mice; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Substance Withdrawal Syndrome; Substance-Related Disorders; Yohimbine | 2002 |